Staurosporine inhibits a tyrosine protein kinase in human hepatoma cell membranes
- PMID: 2167672
- DOI: 10.1016/0006-291x(90)90519-s
Staurosporine inhibits a tyrosine protein kinase in human hepatoma cell membranes
Abstract
Membranes from the human hepatoma cell line HepG2 mediate the phosphorylation on tyrosine of the asialoglycoprotein receptor. Manganese was the preferred divalent for phosphorylation although magnesium was effective at an 8-fold higher concentration. Calcium was ineffective at promoting phosphorylation and zinc was inhibitory. The protein kinase inhibitor staurosporine blocked asialoglycoprotein receptor phosphorylation on tyrosine in nanomolar concentrations (IC50 = 70 nM). In contrast another protein kinase C inhibitor, H7, was not inhibitory, suggesting that the effect of staurosporine was not mediated by protein kinase C inhibition. Concentrations of staurosporine that inhibit receptor phosphorylation by greater than 90% did not inhibit the phosphorylation of other protein substrates identified on SDS-polyacrylamide gels. These data suggest that staurosporine selectively and directly inhibits a membrane-associated tyrosine protein kinase.
Similar articles
-
Staurosporine inhibits the soluble and membrane-bound protein tyrosine kinases of human neutrophils.Biochem Biophys Res Commun. 1991 Jul 31;178(2):423-9. doi: 10.1016/0006-291x(91)90124-p. Biochem Biophys Res Commun. 1991. PMID: 1859401
-
Interleukin 6 signal transduction in a human hepatoma cell line (Hep G2).Immunopharmacol Immunotoxicol. 1993 Aug;15(4):371-86. doi: 10.3109/08923979309035234. Immunopharmacol Immunotoxicol. 1993. PMID: 7693792
-
The effect of staurosporine, a protein kinase inhibitor, on asialoglycoprotein receptor endocytosis.Exp Cell Res. 1992 Dec;203(2):420-6. doi: 10.1016/0014-4827(92)90016-2. Exp Cell Res. 1992. PMID: 1459203
-
Intracellular protein phosphorylation in murine peritoneal macrophages in response to bacterial lipopolysaccharide (LPS): effects of kinase-inhibitors and LPS-induced tolerance.Immunobiology. 1993 Apr;187(3-5):272-82. doi: 10.1016/S0171-2985(11)80344-X. Immunobiology. 1993. PMID: 7687235 Review.
-
The cell membrane as a target for cancer chemotherapy.Eur J Cancer. 1991;27(3):281-4. doi: 10.1016/0277-5379(91)90516-g. Eur J Cancer. 1991. PMID: 1851026 Review. No abstract available.
Cited by
-
Okadaic acid, an inhibitor of protein phosphatases 1 and 2A, inhibits induction of acute-phase proteins by interleukin-6 alone or in combination with interleukin-1 in human hepatoma cell lines.Biochem J. 1992 Jun 15;284 ( Pt 3)(Pt 3):645-8. doi: 10.1042/bj2840645. Biochem J. 1992. PMID: 1377908 Free PMC article.
-
High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.Assay Drug Dev Technol. 2015 Sep;13(7):402-14. doi: 10.1089/adt.2015.655. Assay Drug Dev Technol. 2015. PMID: 26317884 Free PMC article.
-
Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1.Mol Biol Cell. 1996 Jan;7(1):101-111. doi: 10.1091/mbc.7.1.101. Mol Biol Cell. 1996. PMID: 8741843 Free PMC article.
-
Intracellular ATP increases capsaicin-activated channel activity by interacting with nucleotide-binding domains.J Neurosci. 2000 Nov 15;20(22):8298-304. doi: 10.1523/JNEUROSCI.20-22-08298.2000. J Neurosci. 2000. PMID: 11069936 Free PMC article.
-
Mastoparan-induced phosphatidylcholine hydrolysis by phospholipase D activation in human astrocytoma cells.Br J Pharmacol. 1995 Oct;116(3):2090-6. doi: 10.1111/j.1476-5381.1995.tb16416.x. Br J Pharmacol. 1995. PMID: 8640350 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical